Intrexon | XON - Current Assets

Stock Price
3.34
Daily Change
-0.22 -6.06%
Monthly
-22.26%
Yearly
78.34%
Q1 Forecast
3.67

Intrexon reported $23.72M in Current Assets for its fiscal quarter ending in June of 2024.





Current Assets Change Date
Agenus USD 133.95M 120.61M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
Anika Therapeutics USD 101.59M 2.27M Sep/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Heron Therapeutics USD 229.4M 18.48M Sep/2025
Incyte USD 5.02B 746.01M Dec/2025
Intrexon USD 23.72M 45.04M Jun/2024
Karyopharm Therapeutics USD 89.75M 8.12M Sep/2025
Ligand Pharmaceuticals USD 832.27M 78.35M Dec/2025
MacroGenics USD 232.09M 27.15M Sep/2025
MannKind USD 291.58M 67.26M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Rigel Pharmaceuticals USD 214.93M 39.53M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Veracyte USD 488.38M 39.15M Dec/2025
Xencor USD 599.82M 81.38M Dec/2025